NO985896D0 - Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloksybutynin - Google Patents

Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloksybutynin

Info

Publication number
NO985896D0
NO985896D0 NO985896A NO985896A NO985896D0 NO 985896 D0 NO985896 D0 NO 985896D0 NO 985896 A NO985896 A NO 985896A NO 985896 A NO985896 A NO 985896A NO 985896 D0 NO985896 D0 NO 985896D0
Authority
NO
Norway
Prior art keywords
desetyloxybutynin
oxybutynin
treatment
urinary incontinence
incontinence
Prior art date
Application number
NO985896A
Other languages
English (en)
Other versions
NO985896L (no
Inventor
Gunnar Berg
John R Mccullough
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO985896D0 publication Critical patent/NO985896D0/no
Publication of NO985896L publication Critical patent/NO985896L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO985896A 1996-06-28 1998-12-16 Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks NO985896L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/671,976 US5736577A (en) 1995-01-31 1996-06-28 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
PCT/US1997/011570 WO1998000126A1 (en) 1996-06-28 1997-06-27 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin

Publications (2)

Publication Number Publication Date
NO985896D0 true NO985896D0 (no) 1998-12-16
NO985896L NO985896L (no) 1998-12-16

Family

ID=24696647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985896A NO985896L (no) 1996-06-28 1998-12-16 Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks

Country Status (14)

Country Link
US (1) US5736577A (no)
EP (1) EP0914113A1 (no)
JP (1) JP2000513724A (no)
AU (1) AU732568B2 (no)
BR (1) BR9710031A (no)
CA (1) CA2257121C (no)
CZ (1) CZ428398A3 (no)
NO (1) NO985896L (no)
NZ (1) NZ333282A (no)
PL (1) PL190483B1 (no)
RU (1) RU2195276C2 (no)
SK (1) SK178698A3 (no)
UA (1) UA61916C2 (no)
WO (1) WO1998000126A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123961A (en) * 1996-09-25 2000-09-26 Bridge Pharma, Inc. Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin
US6130242A (en) * 1997-12-31 2000-10-10 Sepracor Inc. S-procyclidine for treating urinary incontinence
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
AU767877B2 (en) 1999-05-20 2003-11-27 Sepracor, Inc. Methods for treatment of asthma using S-oxybutynin
AU6403600A (en) * 1999-06-10 2001-01-02 Sepracor, Inc. Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
CA2406064C (en) * 2000-04-26 2011-03-15 Watson Pharmaceuticals, Inc. Minimizing adverse experience associated with oxybutynin therapy
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
ATE355854T1 (de) * 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US6545046B2 (en) * 2000-08-30 2003-04-08 Theramax Inc. Method for enhanced delivery of oxybutynin and compositions thereof
DE10103262A1 (de) * 2001-01-25 2002-08-01 Axel Schmidt-Dossi Arzneimittel gegen Blasenfunktionsstörung
NZ528377A (en) * 2001-03-27 2005-05-27 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
JP2004532874A (ja) * 2001-04-03 2004-10-28 アリックス セラピューティクス 抗コリン作用性化合物および使用法
US20030027856A1 (en) * 2001-06-29 2003-02-06 Aberg A.K. Gunnar Tolterodine metabolites
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
EP1441706A2 (en) * 2001-11-05 2004-08-04 Pharmacia & Upjohn Company Antimuscarinic aerosol
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
BRPI0414551B8 (pt) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
KR20150011379A (ko) * 2007-05-30 2015-01-30 마이크로도스 테라퍼스, 인코포레이티드 옥시부티닌 투여를 위한 방법 및 조성물
JP5782635B2 (ja) * 2011-01-12 2015-09-24 有限会社センチュリーテック 搬送装置
EP3909570A1 (de) * 2020-05-15 2021-11-17 Farco-Pharma GmbH Oxybutynin für die intravesikale anwendung
DE202020103897U1 (de) * 2020-05-15 2021-08-17 Farco-Pharma Gmbh Oxybutynin für die intravesikale Anwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124473C (no) * 1960-07-26
JPH0755904B2 (ja) * 1986-05-14 1995-06-14 小玉株式会社 膀胱疾患治療剤
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
NZ275615A (en) * 1993-09-29 1996-11-26 Alza Corp Oxybutynin composition containing monoglyceride and lactate ester as permeability enhancers; device for transdermal administration of oxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin

Also Published As

Publication number Publication date
BR9710031A (pt) 1999-08-10
NZ333282A (en) 2000-06-23
AU732568B2 (en) 2001-04-26
CA2257121C (en) 2006-10-24
CZ428398A3 (cs) 1999-06-16
SK178698A3 (en) 1999-09-10
WO1998000126A1 (en) 1998-01-08
JP2000513724A (ja) 2000-10-17
CA2257121A1 (en) 1998-01-08
PL330752A1 (en) 1999-05-24
RU2195276C2 (ru) 2002-12-27
AU3513797A (en) 1998-01-21
US5736577A (en) 1998-04-07
PL190483B1 (pl) 2005-12-30
UA61916C2 (en) 2003-12-15
NO985896L (no) 1998-12-16
EP0914113A1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
NO985896L (no) Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks
AU7608396A (en) Devices and methods for assessment and treatment of urinary and fecal incontinence
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
GB9425578D0 (en) redial treatment of urinary incontinence
PL334398A1 (en) Disposable elastic thermal dorsum bandage and method of treating backache
IL138871A0 (en) Flushable diaper and method
AU5729098A (en) Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
EP0954303A4 (en) METHODS FOR TREATING MENTAL ILLNESSES, INFLAMMATION AND PAIN
ZA978427B (en) Method of treating urinary incontinence
AU7408298A (en) Improved incontinence device and method of use
AU9016898A (en) Methods and compositions for treatment of restenosis
NO990914D0 (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
AU3785497A (en) Drug for the prevention or treatment of pollakiuria and urinary incontinence
ZA971607B (en) Methods of treatment of allergic diseases
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
AU2845897A (en) Photosensitive elements and their process of use
AU8809098A (en) Procedure and apparatus for the treatment of waste
GB9626634D0 (en) Wastewater treatment plant and method of use therein
AU6388396A (en) Electromagnetic therapeutic treatment device and methods of using same
EP0909170A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERIC ENRICHED (S) -TRIDIHEXETHYL
IL141264A0 (en) Treatment of fecal incontinence
CZ362797A3 (cs) Způsob zpracování pojiv a jejich použití
ZA98531B (en) Treatment of urinary incontinece